US Supreme Court Turns Away Biogen’s Last Effort To Reinstate Tecfidera Patent
The U.S. Supreme Court decided not to hear the case related to reinstating the patent of Biogen Inc's (NASDAQ: BIIB) blockbuster drug Tecfidera.
Elon Musk Asked That ‘Trump’ Be Added As Search Term For Identifying Spam Accounts And Bots: Report
Elon Musk tried to get Twitter, Inc.
‘Monster Energy Has Been Awarded $293M In Its Lawsuit Against Vital’ – Court Filing
https://www.docdroid.com/nJeh7ej/monster-energy-vs-vital-pharmaceuticals-verdict-pdf#page=2
Barclays Announces An Update On Over-Issuance Under The Barclays Bank PLC U.S. Shelf; BPLC And BBPLC Will Pay A Combined Penalty Of $200M, Without Admitting Or Denying The SEC’s Findings
The U.S. Securities and Exchange Commission ("SEC") has announced the resolution of its investigation of Barclays PLC ("BPLC") and Barclays Bank PLC ("BBPLC") relating to the over-issuance
‘Peloton’s Lawsuit Against Lululemon Dismissed By Judge’ – PeloBuddy
https://www.pelobuddy.com/peloton-lululemon-dismissed/
Peloton’s lawsuit against lululemon – which they preemptively filed last year after receiving a cease and desist letter from
‘Compulsive gambler’s lawsuit claims major Atlantic City casino cut off his online hot streaks, then paid him to keep quiet’ -Fortune Report
https://fortune.com/2022/09/30/borgata-online-gambling-mgm-resorts-lawsuit-sam-antar-compulsive-atlantic-city/?xid=soc_socialflow_twitter_FORTUNE&utm_medium=social&utm_source=twitter.com&utm_campaign=fortunem
Two Former eBay Officials Put Behind Bars for Cyberstalking
The U.S. Department of Justice sentenced two former eBay Inc (NASDAQ: EBAY) executives to prison for their roles in a cyberstalking campaign targeting the editor and publisher of a newsletter that eBay executives viewed as critical of the company.
Acasti Announces Court Dismissal of Stockholder Litigation
LAVAL, Québec, Sept. 30, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. ("Acasti" or the "Company") (NASDAQ:ACST, TSXV:ACST), a late-stage, specialty pharma company advancing three clinical stage